Fast diagnosis has been gaining growing popularity in recent years as it has met market demands. In this connection, we have been committed to developing an analyzer that works in a quick, convenient, accurate and practical manner as part of our commitment to interconnect information with the help of the current electronics technology. This product applies to external detections and is widely used in central labs, clinic and emergency laboratories, clinical departments, other medical service centers (like community ones), medical examination centers and laboratories for scientific researches. The previous test by colloidal gold depends on human eyes for judgment, but this is subject to errors since human eye sights vary from one to another. The new device makes quantitative analysis of test results and makes the process faster and more accurate. The use of device, together with networked data monitoring and reporting and long-distance diagnosis and upgrading services, have minimized errors, made diagnosis faster and central management of hospital information possible. The new device uses an eight inch touch screen with high definition and sensitive touching control. Test results can be uploaded to computers or the Internet automatically which is convenient and user-friendly. Applying mainly to external diagnosis and using recyclable materials, this device leaves no environment footprints or hazardous materials. Its convenience, wireless communications, remote diagnosis and long-distance upgrading mean that the device is not only suitable for clinical diagnosis but also make tests more efficient, accurate and convenient.

The new device uses an eight inch touch screen with high definition and sensitive touching control. Test results can be uploaded to computers or the Internet automatically which is convenient and user-friendly. Applying mainly to external diagnosis and using recyclable materials, this device leaves no environment footprints or hazardous materials. Its convenience, wireless communications, remote diagnosis and long-distance upgrading mean that the device is not only suitable for clinical diagnosis but also make tests more efficient, accurate and convenient.

By the end of, 500 pieces of previous devices have been replaced with an estimated RMB 1.5 million in sales volume. In addition, RMB 2 million worth of consumables have been sold with a 70% gross profit. At the moment, the Company takes over 50% of the market in Shandong Province.

By the end of, 500 pieces of previous devices have been replaced with an estimated RMB 1.5 million in sales volume. In addition, RMB 2 million worth of consumables have been sold with a 70% gross profit. At the moment, the Company takes over 50% of the market in Shandong Province.

Chief Designer: Xu Anqi Other Designers: Liu Guangyan

As a method of microanalysis, fluoroimmunoassay has been gaining momentum in recent years and is among the most sensitive way of microanalysis. Molecules of some materials gives off fluorescent lights by absorbing energy. Fluorimetry makes qualitative and quantitative analysis of materials based on the spectrum and intensity of fluorescence. Fluorescence analysis is highly sensitive and optional. Requiring less sample materials and easier to operate, fluorometry is 2 to 4 levels down from spectrophotometry in terms of floor limits and thus has wide applications in biochemical analysis. Despite the complexity of biochemical measurement, fluoroimmunoassay offers quick clinical analysis and has earned market recognition. Since 2010, the production department, quality department and research & development department have done extensive market researches in its like products and their applications. They have drawn on successful practices and expertise of their counterparts and rolled out the current development scheme. Development of some surveillance projects like CRP have been done by the end of 2011. Development of analysis meters and registration have been completed by the end of February 2012. The first generation of products have been put onto market by the end of October 2013. As of October 2016, we have built on our expertise and developed the device which is named HTY-100 Plus.

Since 2010, the production department, quality department and research & development department have done extensive market researches in its like products and their applications. They have drawn on successful practices and expertise of their counterparts and rolled out the current development scheme. Development of some surveillance projects like CRP have been done by the end of 2011. Development of analysis meters and registration have been completed by the end of February 2012. The first generation of products have been put onto market by the end of October 2013. As of October 2016, we have built on our expertise and developed the device which is named HTY-100 Plus.

By the end of, 500 pieces of previous devices have been replaced with an estimated RMB 1.5 million in sales volume. In addition, RMB 2 million worth of consumables have been sold with a 70% gross profit. At the moment, the Company takes over 50% of the market in Shandong Province.